Recent insider trading activity has been reported across several major companies. Procter & Gamble ($PG) saw insiders trade over $8 million worth of shares, with Officer Gary A. Coombe acquiring and disposing of 35,000 shares of Common Stock and 35,000 shares of Stock Options. T-Mobile US ($TMUS) insiders conducted transactions totaling over $6 million, highlighted by Officer Osvaldik Peter selling 25,000 shares of Common Stock. AMD ($AMD) reported over $12 million in insider trades, with Director and Officer Lisa T. Su acquiring 76,496 shares and disposing of 152,992 shares. McKesson ($MCK) had insider transactions revealing that Director and Officer Tyler Brian S. sold 8,961 shares, totaling over $5 million. Intuit ($INTU) insiders, including Director and Officer Scott D. Cook, sold over $45 million worth of shares, with Cook disposing of 55,848 shares. Pfizer ($PFE) reported two rounds of insider trading, with a total exceeding $38 million; Director and Officer Albert Bourla acquired 582,823 shares and disposed of 1,146,178 shares, while Officer Fonseca Lidia acquired 72,629 shares and disposed of 142,334 shares. Additionally, Lilly Endowment Inc, a 10% owner at Eli Lilly ($LLY), sold over $204 million worth of shares. Other notable transactions included Fiserv ($FI) insiders trading over $3 million, Pepsico ($PEP) with various transactions totaling over $16 million, and Marsh & McLennan Companies ($MMC) with insider trades exceeding $9 million. EOG Resources ($EOG) also reported insider trading exceeding $2 million, while Mastercard ($MA) saw multiple transactions totaling over $2 million. Finally, Moderna CEO Stephane Bancel reported the open market purchase of 102,821 shares at an average price of $31.04 per share on March 3.
It's illegal for insiders to trade on MNPI. Thus, Bancel adding a paltry amount of stock relative to his massive position and massive amount already sold really only means there's no good news coming any time soon. Token buy. $MRNA https://t.co/MlszPIkSL7
$MRNA monster insider buys bancel https://t.co/TchY6hdt8H
$MRNA | Moderna CEO Stephane Bancel Reports Open Market Purchase of 102,821 Shares of Common Stock at Avg Price of 31.04/Share on March 3